The combination treatment regimen of ruxolitinib with low‐dose mercaptopurine or cytarabine in frail patients with blast‐phase myelofibrosis

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles